Vertex Pharmaceuticals Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2018
Total Assets: $6.25B
Liabilities Breakdown FY2018
Total Liabilities: $1.81B
Asset Breakdown
Total Assets: $6.25B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.65B | 42.4% |
| Accounts Receivable | $409.7M | 6.6% |
| Inventory | $124.4M | 2.0% |
| Property, Plant & Equipment | $812.0M | 13.0% |
| Goodwill | $50.4M | 0.8% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.20B | 35.2% |
Liabilities Breakdown
Total Liabilities: $1.81B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $111.0M | 6.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $1.70B | 93.9% |